Search

Your search keyword '"Kinloch, Emma"' showing total 11 results
Start Over Author "Kinloch, Emma"
11 results on '"Kinloch, Emma"'

1. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

Author

Kinloch, Emma, Lam, Emily, Murphy, Gillian, Rhodes, Malcolm, Robinson, Kate, Lee, Lennard Y W, Starkey, Thomas, Ionescu, Maria C, Little, Martin, Tilby, Michael, Tripathy, Arvind R, Mckenzie, Hayley S, Al-Hajji, Youssra, Barnard, Matthew, Benny, Liza, Burnett, Alexander, Cattell, Emma L, Charman, Jackie, Clark, James J, Khan, Sam, Ghafoor, Qamar, Illsley, George, Harper-Wynne, Catherine, Hattersley, Rosie J, Lee, Alvin J X, Leonard, Pauline C, Liu, Justin K H, Pang, Matthew, Pascoe, Jennifer S, Platt, James R, Potter, Vanessa A, Randle, Amelia, Rigg, Anne S, Robinson, Tim M, Roques, Tom W, Roux, René L, Rozmanowski, Stefan, Tuthill, Mark H, Watts, Isabella, Williams, Sarah, Iveson, Tim, Lee, Siow Ming, Middleton, Gary, Middleton, Mark, Protheroe, Andrew, Fittall, Matthew W, Fowler, Tom, and Johnson, Peter

Published
2022
Full Text
View/download PDF

2. Characterising meaningful patient and public involvement in the pharmaceutical industry research setting: a retrospective quality assessment

Author

Dews, Sally-Anne, primary, Bassi, Adit, additional, Buckland, Sean, additional, Clements, Lucy, additional, Daley, Rachel, additional, Davies, Angela, additional, Evett, Sophie, additional, Howland, Samantha, additional, Kinloch, Emma, additional, Phillips, Berkeley, additional, Powell, Gareth, additional, Preston, Jennifer, additional, Sterniczuk, Kamil, additional, and Bohm, Natalie, additional

Published
2023
Full Text
View/download PDF

4. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers:The protocol for the rare head and neck cancers

Author

Trama, Annalisa, Licitra, Lisa, Cavalieri, Stefano, Bonfarnuzzo, Simone, Baili, Paolo, Ciarfella, Antonio, Parente, Pablo, Almadori, Giovanni, Ansarin, Mohssen, Bacigalupo, Almalina, Baumeister, Philipp, Baujat, Bertrand, Bossi, Paolo, Cavalera, Elisa, Cercato, Maria Cecilia, Dieleman, Francois, Fakhry, Nicolas, Ferraresi, Virginia, Gaino, Francesca, Galizia, Danilo, Halamkova, Jana, Halme, Elina, Hardillo, Jose, Hofauer, Benedikt, Kinloch, Emma, Livi, Lorenzo, Locati, Laura Deborah, Mattheis, Stefan, Mercante, Giuseppe, Mirabile, Aurora, Molteni, Gabriele, Orlandi, Ester, Persio, Roberto, Sciallero, Stefania, Smeele, Ludi, Tagliabue, Marta, Valentini, Valentino, Van Harpen, Carla, Westphalen, Christoph Benedikt, Botta, Laura, Trama, Annalisa, Licitra, Lisa, Cavalieri, Stefano, Bonfarnuzzo, Simone, Baili, Paolo, Ciarfella, Antonio, Parente, Pablo, Almadori, Giovanni, Ansarin, Mohssen, Bacigalupo, Almalina, Baumeister, Philipp, Baujat, Bertrand, Bossi, Paolo, Cavalera, Elisa, Cercato, Maria Cecilia, Dieleman, Francois, Fakhry, Nicolas, Ferraresi, Virginia, Gaino, Francesca, Galizia, Danilo, Halamkova, Jana, Halme, Elina, Hardillo, Jose, Hofauer, Benedikt, Kinloch, Emma, Livi, Lorenzo, Locati, Laura Deborah, Mattheis, Stefan, Mercante, Giuseppe, Mirabile, Aurora, Molteni, Gabriele, Orlandi, Ester, Persio, Roberto, Sciallero, Stefania, Smeele, Ludi, Tagliabue, Marta, Valentini, Valentino, Van Harpen, Carla, Westphalen, Christoph Benedikt, and Botta, Laura

Abstract

Care for head and neck cancers is complex in particular for the rare ones. Knowledge is limited and histological heterogeneity adds complexity to the rarity. There is a wide consensus that to support clinical research on rare cancer, clinical registries should be developed within networks specializing in rare cancers. In the EU, a unique opportunity is provided by the European Reference Networks (ERN). The ERN EURACAN is dedicated to rare adults solid cancers, here we present the protocol of the EURACAN registry on rare head and neck cancers (ClinicalTrials.gov Identifier: NCT05483374). Study design Registry-based cohort study including only people with rare head and neck cancers. Objectives 1.To help describe the natural history of rare head and neck cancers; 2.To evaluate factors that influence prognosis; 3.To assess treatment effectiveness; 4.To measure indicators of quality of care. Methods Settings and participants It is an hospital based registry established in hospitals with expertise in head and neck cancers. Only adult patients with epithelial tumours of nasopharynx; nasal cavity and paranasal sinuses; salivary gland cancer in large and small salivary glands; and middle ear will be included in the registry. This registry won t select a sample of patients. Each patient in the facility who meets the above mentioned inclusion criteria will be followed prospectively and longitudinally with follow-up at cancer progression and / or cancer relapse or patient death. It is a secondary use of data which will be collected from the clinical records. The data collected for the registry will not entail further examinations or admissions to the facility and/or additional appointments to those normally provided for the patient follow-up. Variables Data will be collected on patient characteristics (eg. patient demographics, lifestyle, medical history, health status); exposure data (eg. disease, procedures, treatments of interest) and outcomes (e.g. survival, progression

Published
2023

6. The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers

Author

Trama, Annalisa, primary, Licitra, Lisa, additional, Cavalieri, Stefano, additional, Bonfarnuzzo, Simone, additional, Baili, Paolo, additional, Ciarfella, Antonio, additional, Parente, Pablo, additional, Almadori, Giovanni, additional, Ansarin, Mohssen, additional, Bacigalupo, Almalina, additional, Baumeister, Philipp, additional, Baujat, Bertrand, additional, Bossi, Paolo, additional, Cavalera, Elisa, additional, Cercato, Maria Cecilia, additional, Dieleman, Francois, additional, Fakhry, Nicolas, additional, Ferraresi, Virginia, additional, Gaino, Francesca, additional, Galizia, Danilo, additional, Halamkova, Jana, additional, Halme, Elina, additional, Hardillo, Jose, additional, Hofauer, Benedikt, additional, Kinloch, Emma, additional, Livi, Lorenzo, additional, Locati, Laura Deborah, additional, Mattheis, Stefan, additional, Mercante, Giuseppe, additional, Mirabile, Aurora, additional, Molteni, Gabriele, additional, Orlandi, Ester, additional, Persio, Roberto, additional, Sciallero, Stefania, additional, Smeele, Ludi, additional, Tagliabue, Marta, additional, Valentini, Valentino, additional, Van Harpen, Carla, additional, Westphalen, Christoph Benedikt, additional, and Botta, Laura, additional

Published
2023
Full Text
View/download PDF

7. COVID-19: Third dose booster vaccine effectiveness against breakthrough coronavirus infection, hospitalisations and death in patients with cancer: A population-based study

Author

Lee, Lennard Y.W., primary, Ionescu, Maria C., additional, Starkey, Thomas, additional, Little, Martin, additional, Tilby, Michael, additional, Tripathy, Arvind R., additional, Mckenzie, Hayley S., additional, Al-Hajji, Youssra, additional, Appanna, Nathan, additional, Barnard, Matthew, additional, Benny, Liza, additional, Burnett, Alexander, additional, Cattell, Emma L., additional, Clark, James J., additional, Khan, Sam, additional, Ghafoor, Qamar, additional, Panneerselvam, Hari, additional, Illsley, George, additional, Harper-Wynne, Catherine, additional, Hattersley, Rosie J., additional, Lee, Alvin JX., additional, Lomas, Oliver, additional, Liu, Justin KH., additional, McCauley, Amanda, additional, Pang, Matthew, additional, Pascoe, Jennifer S., additional, Platt, James R., additional, Patel, Grisma, additional, Patel, Vijay, additional, Potter, Vanessa A., additional, Randle, Amelia, additional, Rigg, Anne S., additional, Robinson, Tim M., additional, Roques, Tom W., additional, Roux, René L., additional, Rozmanowski, Stefan, additional, Taylor, Harriet, additional, Tuthill, Mark H., additional, Watts, Isabella, additional, Williams, Sarah, additional, Beggs, Andrew, additional, Iveson, Tim, additional, Lee, Siow M., additional, Middleton, Gary, additional, Middleton, Mark, additional, Protheroe, Andrew, additional, Fittall, Matthew W., additional, Fowler, Tom, additional, Johnson, Peter, additional, Kinloch, Emma, additional, Lam, Emily, additional, Murphy, Gillian, additional, Rhodes, Malcolm, additional, Robinson, Kate, additional, Swarup, Sanskriti, additional, Bernhardt, Keeley, additional, Bytyci, Jola, additional, Ying, Yuxin, additional, Johal, Sukhmunni, additional, and Sheehan, Remarez, additional

Published
2022
Full Text
View/download PDF

8. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement:updated reporting guidance for health economic evaluations

Author

Husereau, Don, Drummond, Michael, Augustovski, Federico, de Bekker-Grob, Esther, Briggs, Andrew H., Carswell, Chris, Caulley, Lisa, Chaiyakunapruk, Nathorn, Greenberg, Dan, Loder, Elizabeth, Mauskopf, Josephine, Mullins, C. Daniel, Petrou, Stavros, Pwu, Raoh Fang, Staniszewska, Sophie, Jakab, Ivett, Kinloch, Emma, Low, Eric, Mossman, Jean, Noone, Declan, Posner, Phil, Watson, Jo, Babidge, Wendy, Beamesderfer, Lyn, Beerens, Dior, Cryer, Tillie, Donnelly, Ana, Espinoza, Manuel, Greiner, Wolfgang, Happe, Laura, Hiligsmann, Mickaël, Laine, Christine, Lee, Lin, Lee, Ken, Pafitis, Natalie, Robinson, Julia, Stein, Kenneth, Szunyogova, Eva, Weber, Wim, Wrightson, Timothy, Zikmund-Fisher, Brian, Aubin, Marie Claude, Berger, Marc, Campbell, John, Coyle, Doug, Dyer, Matthew, Edlin, Richard, Faria, Rita, Gallegos, Veronica, Luo, Nan, Husereau, Don, Drummond, Michael, Augustovski, Federico, de Bekker-Grob, Esther, Briggs, Andrew H., Carswell, Chris, Caulley, Lisa, Chaiyakunapruk, Nathorn, Greenberg, Dan, Loder, Elizabeth, Mauskopf, Josephine, Mullins, C. Daniel, Petrou, Stavros, Pwu, Raoh Fang, Staniszewska, Sophie, Jakab, Ivett, Kinloch, Emma, Low, Eric, Mossman, Jean, Noone, Declan, Posner, Phil, Watson, Jo, Babidge, Wendy, Beamesderfer, Lyn, Beerens, Dior, Cryer, Tillie, Donnelly, Ana, Espinoza, Manuel, Greiner, Wolfgang, Happe, Laura, Hiligsmann, Mickaël, Laine, Christine, Lee, Lin, Lee, Ken, Pafitis, Natalie, Robinson, Julia, Stein, Kenneth, Szunyogova, Eva, Weber, Wim, Wrightson, Timothy, Zikmund-Fisher, Brian, Aubin, Marie Claude, Berger, Marc, Campbell, John, Coyle, Doug, Dyer, Matthew, Edlin, Richard, Faria, Rita, Gallegos, Veronica, and Luo, Nan

Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making.

Published
2022

9. Vaccine effectiveness against COVID-19 breakthrough infections in patients with cancer (UKCCEP): a population-based test-negative case-control study

Author

Lee, Lennard Y W, primary, Starkey, Thomas, additional, Ionescu, Maria C, additional, Little, Martin, additional, Tilby, Michael, additional, Tripathy, Arvind R, additional, Mckenzie, Hayley S, additional, Al-Hajji, Youssra, additional, Barnard, Matthew, additional, Benny, Liza, additional, Burnett, Alexander, additional, Cattell, Emma L, additional, Charman, Jackie, additional, Clark, James J, additional, Khan, Sam, additional, Ghafoor, Qamar, additional, Illsley, George, additional, Harper-Wynne, Catherine, additional, Hattersley, Rosie J, additional, Lee, Alvin J X, additional, Leonard, Pauline C, additional, Liu, Justin K H, additional, Pang, Matthew, additional, Pascoe, Jennifer S, additional, Platt, James R, additional, Potter, Vanessa A, additional, Randle, Amelia, additional, Rigg, Anne S, additional, Robinson, Tim M, additional, Roques, Tom W, additional, Roux, René L, additional, Rozmanowski, Stefan, additional, Tuthill, Mark H, additional, Watts, Isabella, additional, Williams, Sarah, additional, Iveson, Tim, additional, Lee, Siow Ming, additional, Middleton, Gary, additional, Middleton, Mark, additional, Protheroe, Andrew, additional, Fittall, Matthew W, additional, Fowler, Tom, additional, Johnson, Peter, additional, Kinloch, Emma, additional, Lam, Emily, additional, Murphy, Gillian, additional, Rhodes, Malcolm, additional, and Robinson, Kate, additional

Published
2022
Full Text
View/download PDF

10. Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations.

Author

Husereau, Don, Drummond, Michael, Augustovski, Federico, de Bekker-Grob, Esther, Briggs, Andrew H., Carswell, Chris, Caulley, Lisa, Chaiyakunapruk, Nathorn, Greenberg, Dan, Loder, Elizabeth, Mauskopf, Josephine, Mullins, C. Daniel, Petrou, Stavros, Pwu, Raoh-Fang, Staniszewska, Sophie, CHEERS 2022 ISPOR Good Research Practices Task Force, Jakab, Ivett, Kinloch, Emma, Low, Eric, and Mossman, Jean

Abstract

Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was created to ensure health economic evaluations are identifiable, interpretable, and useful for decision making. It was intended as guidance to help authors report accurately which health interventions were being compared and in what context, how the evaluation was undertaken, what the findings were, and other details that may aid readers and reviewers in interpretation and use of the study. The new CHEERS 2022 statement replaces previous CHEERS reporting guidance. It reflects the need for guidance that can be more easily applied to all types of health economic evaluation, new methods and developments in the field, as well as the increased role of stakeholder involvement including patients and the public. It is also broadly applicable to any form of intervention intended to improve the health of individuals or the population, whether simple or complex, and without regard to context (such as health care, public health, education, social care, etc.). This summary article presents the new CHEERS 2022 28-item checklist and recommendations for each item. The CHEERS 2022 statement is primarily intended for researchers reporting economic evaluations for peer reviewed journals as well as the peer reviewers and editors assessing them for publication. However, we anticipate familiarity with reporting requirements will be useful for analysts when planning studies. It may also be useful for health technology assessment bodies seeking guidance on reporting, as there is an increasing emphasis on transparency in decision making. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results